Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Moderna, Inc.(MRNA) | 4,632,149 | 4,632,149 | 0 | $550.07M | $309.57M | 52.30% | -$240.50M |
| Foghorn Therapeutics Inc.(FHTX) | 12,674,120 | 12,674,120 | 0 | $72.88M | $118.00M | 19.94% | +$45.12M |
| Sana Biotechnology, Inc.(SANA) | 25,001,856 | 25,001,856 | 0 | $136.51M | $104.01M | 17.57% | -$32.50M |
| Omega Therapeutics Inc | 29,225,579 | 29,225,579 | 0 | $60.50M | $35.66M | 6.02% | -$24.84M |
| Seres Therapeutics, Inc.(MCRB) | 23,117,045 | 23,117,045 | 0 | $16.73M | $21.87M | 3.70% | +$5.14M |
| Syros Pharmaceuticals Inc | 1,293,849 | 1,293,849 | 0 | $6.68M | $2.78M | 0.47% | -$3.89M |